1. Anti-infection
  2. Bacterial Antibiotic
  3. Pretomanid

Pretomanid  (Synonyms: PA-824; (S)-PA 824)

Cat. No.: HY-10844 Purity: 99.91%
Handling Instructions Technical Support

Pretomanid (PA-824) is an antibiotic used for the research of multi-drug-resistant tuberculosis affecting the lungs. Pretomanid exhibits a sub-micromolar MIC against M. tuberculosis (MTB). The MIC values of PA-824 against a panel of MTB pan-sensitive and Rifampin mono-resistant clinical isolates range from 0.015 to 0.25 μg/mL.

For research use only. We do not sell to patients.

CAS No. : 187235-37-6

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 11 publication(s) in Google Scholar

Other Forms of Pretomanid:

Top Publications Citing Use of Products

    Pretomanid purchased from MedChemExpress. Usage Cited in: Molecules. 2024 Aug 26;29(17):4041.  [Abstract]

    viability data obtained from cells after 72 h of incubation in the presence of different concentrations of Pretomanid.

    Pretomanid purchased from MedChemExpress. Usage Cited in: Molecules. 2024 Aug 26;29(17):4041.  [Abstract]

    Representative flow cytometry graphs showing ROS production by the axenic amastigote cultures of L. infantum-iRFP stained with DCFH-DA after the 0.28 μM Pretomanid.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Pretomanid (PA-824) is an antibiotic used for the research of multi-drug-resistant tuberculosis affecting the lungs. Pretomanid exhibits a sub-micromolar MIC against M. tuberculosis (MTB). The MIC values of PA-824 against a panel of MTB pan-sensitive and Rifampin mono-resistant clinical isolates range from 0.015 to 0.25 μg/mL.

    IC50 & Target

    Tuberculosis.

    Cellular Effect
    Cell Line Type Value Description References
    HEK293 CC50
    98 μM
    Compound: 2
    Cytotoxicity against human HEK293 cells assessed as reduction in cell viability after 20 hrs
    Cytotoxicity against human HEK293 cells assessed as reduction in cell viability after 20 hrs
    [PMID: 33151678]
    HEK293 IC50
    > 30 μM
    Compound: 1, PA-824
    Inhibition of human Erg expressed in HEK293 cells by FAST patch clamp analysis
    Inhibition of human Erg expressed in HEK293 cells by FAST patch clamp analysis
    [PMID: 22148391]
    MRC5 IC50
    > 64 μM
    Compound: S-1; PA-824
    Cytotoxicity against human MRC5 cells after 72 hrs by resazurin dye based assay
    Cytotoxicity against human MRC5 cells after 72 hrs by resazurin dye based assay
    [PMID: 29461823]
    Vero IC50
    44 μg/mL
    Compound: PA-824
    Cytotoxicity against African green monkey Vero cells by cell titer glo assay
    Cytotoxicity against African green monkey Vero cells by cell titer glo assay
    [PMID: 26711150]
    Vero IC50
    > 100 μM
    Compound: 4; PA-824
    Cytotoxicity against African green monkey Vero cells assessed by reduction in cell viability incubated for 72 hrs by resazurin dye fluorescence based assay
    Cytotoxicity against African green monkey Vero cells assessed by reduction in cell viability incubated for 72 hrs by resazurin dye fluorescence based assay
    [PMID: 34046598]
    Vero IC50
    > 100 μg/mL
    Compound: PA824
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS-PMS assay
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS-PMS assay
    [PMID: 24087924]
    Vero IC50
    > 125 μM
    Compound: 1, PA-824
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS assay
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS assay
    [PMID: 19928920]
    Vero IC50
    > 128 μM
    Compound: 1, PA-824
    Cytotoxicity against african green monkey Vero cells after 72 hrs by tetrazolium dye assay
    Cytotoxicity against african green monkey Vero cells after 72 hrs by tetrazolium dye assay
    [PMID: 19968290]
    Vero IC50
    > 128 μM
    Compound: 1, PA-824
    Cytotoxicity against African green monkey Vero cells after 72 hrs
    Cytotoxicity against African green monkey Vero cells after 72 hrs
    [PMID: 26253632]
    Vero IC50
    > 128 μM
    Compound: PA-824
    Cytotoxicity against african green monkey Vero cells after 72 hrs
    Cytotoxicity against african green monkey Vero cells after 72 hrs
    [PMID: 21691438]
    Vero IC50
    > 128 μM
    Compound: PA-824
    Cytotoxicity against African green monkey Vero cells assessed as cell viability after 72 hrs by CellTiter 96 assay
    Cytotoxicity against African green monkey Vero cells assessed as cell viability after 72 hrs by CellTiter 96 assay
    [PMID: 24909079]
    In Vitro

    Pretomanid (PA-824) showed significant activity at 2, 10, and 50 microg/ml, similar to that of metronidazole, in a dose-dependent manner[2].
    Pretomanid (PA-824) has no effect on the viability of M. leprae in all three models, consistent with the lack of the nitroimidazo-oxazine-specific nitroreductase, encoded by Rv3547 in the M. leprae genome, which is essential for activation of this molecule[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Pretomanid (PA-824) exhibited a sub-micromolar minimal inhibitory concentration (MIC) against MTB, Although Pretomanid (PA-824) was not the most potent NAP against cultured MTB clinical isolates, it was the most active in infected mice when orally administered at 25 mg/kg. This indicated that Pretomanid (PA-824) might possess more desirable pharmacokinetic properties than the other more potent NAP compounds that we tested. Further studies in mice at 25, 50 and 100 mg/kg Pretomanid (PA-824) daily for 10 days resulted in reductions of mycobacterial burden in both spleen and lung tissues that were comparable to that of INH at 25 mg/kg[1].
    Pretomanid (PA-824) at 100 mg/kg in cyclodextrin/lecithin was as active as moxifloxacin at 100 mg/kg and isoniazid at 25 mg/kg and was slightly more active than rifampin at 20 mg/kg. Long-term treatment with Pretomanid (PA-824) at 100 mg/kg in cyclodextrin/lecithin reduced the bacterial load below 500 CFU in the lungs and spleen[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    Molecular Weight

    359.26

    Formula

    C14H12F3N3O5

    CAS No.
    Appearance

    Solid

    Color

    Off-white to yellow

    SMILES

    FC(F)(F)OC(C=C1)=CC=C1CO[C@@H]2COC3=NC([N+]([O-])=O)=CN3C2

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 1 year
    -20°C 6 months
    Solvent & Solubility
    In Vitro: 

    DMSO : 125 mg/mL (347.94 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Ethanol : 12.5 mg/mL (34.79 mM; Need ultrasonic)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.7835 mL 13.9175 mL 27.8350 mL
    5 mM 0.5567 mL 2.7835 mL 5.5670 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 2.08 mg/mL (5.79 mM); Clear solution; Need ultrasonic

      This protocol yields a clear solution of 2.08 mg/mL.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: 2.08 mg/mL (5.79 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.91%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    Ethanol / DMSO 1 mM 2.7835 mL 13.9175 mL 27.8350 mL 69.5875 mL
    5 mM 0.5567 mL 2.7835 mL 5.5670 mL 13.9175 mL
    10 mM 0.2783 mL 1.3917 mL 2.7835 mL 6.9587 mL
    15 mM 0.1856 mL 0.9278 mL 1.8557 mL 4.6392 mL
    20 mM 0.1392 mL 0.6959 mL 1.3917 mL 3.4794 mL
    25 mM 0.1113 mL 0.5567 mL 1.1134 mL 2.7835 mL
    30 mM 0.0928 mL 0.4639 mL 0.9278 mL 2.3196 mL
    DMSO 40 mM 0.0696 mL 0.3479 mL 0.6959 mL 1.7397 mL
    50 mM 0.0557 mL 0.2783 mL 0.5567 mL 1.3917 mL
    60 mM 0.0464 mL 0.2320 mL 0.4639 mL 1.1598 mL
    80 mM 0.0348 mL 0.1740 mL 0.3479 mL 0.8698 mL
    100 mM 0.0278 mL 0.1392 mL 0.2783 mL 0.6959 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Pretomanid
    Cat. No.:
    HY-10844
    Quantity:
    MCE Japan Authorized Agent: